BPC-157 for Arthritis Research: Study Type Comparison
Chemically Induced OA (Rat) Cartilage thickness, proteoglycan content 10–50 μg/kg daily 14–28 days Preserved cartilage thickness vs controls; reduced MMP-13 expression Strong evidence for chondroprotective effect in acute damage models Adjuvant-Induced RA (Rat
This comparison does not assign a generated winner or score.
- Chemically Induced OA (Rat)
- Cartilage thickness, proteoglycan content
- 10–50 μg/kg daily
- 14–28 days
- Preserved cartilage thickness vs controls; reduced MMP-13 expression
- Strong evidence for chondroprotective effect in acute damage models
- Adjuvant-Induced RA (Rat)
- Joint swelling, synovial inflammation
- 10 μg/kg daily
- 28 days
- 42% reduction in paw swelling; decreased TNF-alpha and IL-1β in synovial fluid
- Demonstrates anti-inflammatory mechanism distinct from NSAIDs
- Surgical Meniscectomy (Rat)
- Subchondral bone changes, osteophyte formation
- 12 weeks
- Reduced bone marrow lesions; slower osteophyte progression
- Long-term study suggests disease-modifying potential, not just symptom control
- Tendon-to-Bone Healing (Rat)
- Collagen fiber alignment, biomechanical strength
- 10–20 μg/kg daily
- 21 days
- 40% increase in collagen synthesis; improved tensile strength at 21 days
- Mechanism applicable to ligament/tendon damage in arthritis
- In Vitro Chondrocyte Culture
- Gene expression (COL2A1, ACAN)
- 1–10 μg/mL
- 48–72 hours
- Upregulated type II collagen and aggrecan expression
- Direct cellular evidence of cartilage anabolic effect